72250-0001 NDC - METABOLIC SUPPORT (FUCUS VESICULOSUS, AGNUS CASTUS, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHYTOLACCA DECANDRA, KALI PHOSPHORICUM, MAGNESIA PHOSPHORICA, CARBO VEGETABILIS, GRAPHITES, CALCAREA CARBONICA, NATRUM PHOSPHORICUM, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, THYROIDINUM (SUIS))

Drug Information

Product NDC: 72250-0001
Proprietary Name: Metabolic Support
Non Proprietary Name: Fucus Vesiculosus, Agnus Castus, Chelidonium Majus, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phytolacca Decandra, Kali Phosphoricum, Magnesia Phosphorica, Carbo Vegetabilis, Graphites, Calcarea Carbonica, Natrum Phosphoricum, Hypophysis Suis, Placenta Totalis Suis, Thyroidinum (Suis)
Active Ingredient(s): 10 [hp_X]/mL ACTIVATED CHARCOAL; 6 [hp_X]/mL CHASTE TREE; 6 [hp_X]/mL CHELIDONIUM MAJUS; 8 [hp_X]/mL DIBASIC POTASSIUM PHOSPHATE; 4 [hp_X]/mL FUCUS VESICULOSUS; 10 [hp_X]/mL GRAPHITE; 6 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE; 8 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 6 [hp_X]/mL PHYTOLACCA AMERICANA ROOT; 6 [hp_X]/mL SODIUM CHLORIDE; 12 [hp_X]/mL SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; 6 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 12 [hp_X]/mL SUS SCROFA HYPOTHALAMUS; 12 [hp_X]/mL SUS SCROFA PITUITARY GLAND; 12 [hp_X]/mL SUS SCROFA PLACENTA; 12 [hp_X]/mL SUS SCROFA THYROID
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Pharmacy Class(es): Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name	Field Value
Labeler Name:	BodyLogicMD of Fort Lauderdale
Product Type:	HUMAN OTC DRUG
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	5/31/2018

Package Information

No.	Package Code	Package Description	Billing Unit
1	72250-0001-1	59 mL in 1 BOTTLE, DROPPER (72250-0001-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	72250-0001	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN OTC DRUG	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME	Metabolic Support	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME	Fucus Vesiculosus, Agnus Castus, Chelidonium Majus, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phytolacca Decandra, Kali Phosphoricum, Magnesia Phosphorica, Carbo Vegetabilis, Graphites, Calcarea Carbonica, Natrum Phosphoricum, Hypophysis Suis, Placenta Totalis Suis, Thyroidinum (Suis)	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
ROUTE NAME	ORAL	The translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE	5/31/2018	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	BodyLogicMD of Fort Lauderdale	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ACTIVATED CHARCOAL; CHASTE TREE; CHELIDONIUM MAJUS; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA THYROID	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	10; 6; 6; 8; 4; 10; 6; 8; 12; 6; 6; 12; 6; 12; 12; 12; 12
ACTIVE INGRED UNIT	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
PHARM CLASSES	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Drug Information

Labeler Information

Package Information

NDC Record

Download Record